Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Flows From Operating Activities
Net loss	$ (5,964,823)	$ (10,795,810)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	10,570	12,500
Amortization of patents	503,340	503,340
Issuance of stock for services	80,000
Changes in operating assets and liabilities
Settlement receivable	434,040	275,941
Prepaid Expense	192,643	35,139
Accounts payable - trade	(810,036)	1,799,409
Other accrued expenses	462,409	(114,462)
Accrued interest expense	697,214	401,592
Net Cash Used In Operating Activities	(4,394,643)	(7,882,351)
Cash Flows From Investing Activities
Purchase of fixed assets	0	(25,639)
Net Cash Used In Investing Activities	0	(25,639)
Cash Flows From Financing Activities
Proceeds from issuance of convertible notes payable	2,556,000	2,950,000
Proceeds from issuance of convertible notes payable - related party	1,350,000	4,000,000
Proceeds from exercise of warrants	615,059	533
Net Cash Provided By Financing Activities	4,521,059	6,950,533
Net Change In Cash and Cash Equivalents	126,416	(957,457)
Cash and Cash Equivalents, Beginning of Period	105,504	1,165,738
Cash and Cash Equivalents, End of Period	231,920	208,281
Non-cash investing and financing activities:
Conversion of preferred stock into common stock		3,987
Dividend paid-in kind to preferred shareholders		1,595
Issuance in-kind of preferred stock dividends		14,107
Reclassification of warrant liability
Common stock issued in satisfaction of trade debt		17,300
Notes payable issued in satisfaction of trade debt		$ 150,000